In vivo and in vitro antitumor activity of butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase inhibitor, in human prostate cancer.

In vivo and in vitro antitumor activity of butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase inhibitor, in human prostate cancer.

Item
http://www.wikidata.org/entity/Q33213396
Epigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomasDisparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumor.Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formationIn vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomasHistone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma.The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with DoxorubicinSolid tumor differentiation therapy - is it possible?Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicityFunctions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.Mechanism of growth inhibition of prostate cancer xenografts by valproic acid.Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer.AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair.Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
P2860

In vivo and in vitro antitumor activity of butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase inhibitor, in human prostate cancer.

Item
http://www.wikidata.org/entity/Q33213396
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
In vivo and in vitro antitumor ...... tor, in human prostate cancer.
@ast
In vivo and in vitro antitumor ...... tor, in human prostate cancer.
@en
type
label
In vivo and in vitro antitumor ...... tor, in human prostate cancer.
@ast
In vivo and in vitro antitumor ...... tor, in human prostate cancer.
@en
prefLabel
In vivo and in vitro antitumor ...... tor, in human prostate cancer.
@ast
In vivo and in vitro antitumor ...... tor, in human prostate cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
In vivo and in vitro antitumor ...... tor, in human prostate cancer.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698